Acurx Pharmaceuticals Inc.

ACXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

-$0.06 (-4.32%)

At close: Sep 21, 2026, 4:00 PM ET

$1.31

-$0.02 (-1.50%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-7.97M	-14.1M	-14.58M	-12.09M	-12.75M	-4.6M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.57M	3.44M	3.77M	3.3M	6.74M	1.27M
Other Working Capital	-393.67K	206.06K	1.14M	1.25M	141.28K	-801.17K
Other Non-Cash Items	n/a	n/a	n/a	n/a	850.26K	781.7K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-390.96K	284.09K	1.01M	1.25M	141.28K	-801.17K
Operating Cash Flow	-6.79M	-10.38M	-9.8M	-7.54M	-5.01M	-3.35M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	66.5K
Common Stock Repurchased	-1.04K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	210.2K	2.22M	13	n/a	n/a
Financial Cash Flow	10.64M	6.62M	8.16M	3.7M	14.8M	4.04M
Net Cash Flow	3.85M	-3.77M	-1.64M	-3.85M	9.78M	692.09K
Free Cash Flow	-6.79M	-10.38M	-9.8M	-7.54M	-5.01M	-3.35M
Adj. Free Cash Flow	-8.36M	-13.82M	-13.57M	-10.84M	-11.76M	-4.62M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-6.79M	-10.38M	-9.8M	-7.54M	-5.01M	-3.35M